Directory · DE
Biotechnology in Germany
A register of firms and the professionals working at them in the Biotechnology sector based in Germany. Browse the public index, then filter or export on Kipplo.
Companies
237 on file
Bionfarming
BionFarming is unlocking the full potential of molecular farming and revolutionising the development and accessibility of powerful algae-based pharmaceuticals, medical foods and ecological applications. Our mission is to create healthy, environmentally friendly and affordable algae-based biotech products by pushing the scientific boundaries to expand the range of recombinant products and enable sustainable production. We aim to revolutionise the development, cost and accessibility of sustainable algae-based products.
11 to 50 staff
Biotez
Partner for Immunochemistry Solutions & Assay Manufacturer! Assay Development & Validation, OEM manufacturing, Individual Kit Components, Coatings & Conjugate; Customized Microplates; Polystreptavidin Platform surface functionalization ideal for Quick Tests Streptavidin coated beads & plates; Labelled Streptavidin with Poly HRP, POD, Gold, FITC, Europium or Carbon Black Protein, Antibodies & ELISA for Therapeutic Drug Monitoring; Parkinson: Protein, Antibodies and ELISA COMT, MAO-B, DDC; Rheumatism: Adalimumab/TNFa Cardio vascular: Evolocumab/PCSK9; Allergy: Omalizumab/IgE diagnostics Customized Gel & Columns for Affinity Chromatography; Mycotoxin & Vitamin Clean-up Columns; DNA/RNA Primer Synthesis; Drug Discovery: Human Proteases & Enzymes & Proteins With the unique recoveryELISA technology it is possible to monitor the free drug (e.g. Omalizumab, Adalimumab, Infliximab and Evolocumb) the free antigen (e.g. IgE, TNFa and PCSK9) concentration and the neutralization rate of in patient sera during biological therapy. This next generation therapeutic drug monitoring (TDM) tool can be used by diagnostic laboratories and medical doctors for research to find a personalized medication dose for each patient individually. Improve the Streptavidin-Biotin binding capacity with high signal for your applications using our exclusive Poly-streptavidin. Highly effective Immuno-affinity Columns for mycotoxin analysis and custom applications Development of custom Labelling of Antibodies and other biomolecules. Services in ELISA and Lateral Flow Quick Test development.
11 to 50 staff
Celldeg Gmbh
CellDEG GmbH was founded 2016 and is a spin-off from the Institute of Biology at the Humboldt University of Berlin. Members of the former Cell Biology group headed by Prof. Dr. Rudolf Ehwald developed the High-Density Cultivation (HDC) process for optimal CO2 and light supply of cyanobacteria and microalgae. Compared to classical culture methods, the productivity of photoautotrophic microorganisms can thus be increased several folds. The technology is based on highly efficient membrane-mediated CO2 transfer into turbulently moving cell suspensions. In combination with strong light and nutrient-enriched media, unprecedented volume- and area-based biomass productivities up to very high cell densities (≥ 30 g dw L-1) can be generated in this way. Features such as the avoidance of carbon and light limitation, disturbingly high oxygen concentrations, bubble flow-induced shear stress, negligible CO2 and water vapor losses to the atmosphere as well as the possibility of axenic cultivation make this system unique. Based on this technology, CellDEG has developed parallel screening and analysis platforms as well as bioreactors for the production of axenic biomass at laboratory scale. All cultivators offered can be connected to a central control unit and enable a convenient and time-saving workflow. These highly innovative cultivation systems are marketed primarily to research institutions and biomass producers who want to grow cyanobacteria and microalgae quickly, in parallel and reliably. CellDEG aims to establish a standardized highly efficient technology for photoautotrophic cultures that allows reproducibility of experimental approaches across laboratories. The associated sensor technology and analytics, as well as the transfer of the technology to the pilot plant scale, are also key areas of focus.
1 to 10 staff
Cellerna Bioscience
Cellerna was founded by scientists and entrepreneurs from academia and industry. We believe in the disruptive potential of mRNA technology in biological research and modern medicine. With 30+ years of combined experience, we strive to provide best-in-class mRNAs that enable cutting-edge discoveries. We provide best-in-class synthetic messenger RNAs (mRNAs) that are stealth with regards to the innate immune sensors boosting expression and allowing repeated administration. We offer mRNAs either in un-encapsulated and ionizable LNP-encapsulated forms to enable the expression of proteins in cell lines, primary cells and in vivo models. Our Products and Services- Stocked mRNAs - Custom mRNA synthesis - In vitro transcription (IVT) mRNA from template catalog - Custom DNA & RNA oligos - sgRNA - Primers - Probes
1 to 10 staff
Cellphenomics Gmbh
CELLphenomics is a thriving and diverse place to work and learn. We offer fee-for-service research as well as research projects with academic partners on the local, national and EU level. Our partners, clients and staff, with representation from more than 20 countries, are brought together by the common goal of translational research.
11 to 50 staff
Clib - Cluster Industrielle Biotechnologie
CLIB (Cluster Industrial Biotechnology) is an international open innovation cluster of large companies, SMEs, academic institutes and universities, as well as other stakeholders active in biotechnology and bioeconomy as a whole. The cluster comprises over 100 members with a share of about 25 % international members. The overall goal of CLIB is to network stakeholders along and across value chains and to identify new opportunities for innovation, projects, and business. Through this, the cluster develops cross-sectoral biotechnological solutions for sustainable processes and products. Pertinent project areas are identified by the CLIB team in conjunction with members in an iterative process. CLIB is a non-profit association, with its members shaping the cluster’s interests and activities. The cluster coordinates several associated programmes which cover different aspects of bioeconomy, and invites members to become involved, bring in their own ideas and to generate a real benefit for their companies or institutions. To this end, CLIB organises a number of events throughout the year: the annual CLIB international conference (CIC), forum events, topic-specific workshops, dedicated small partnering meetings and visits to partners, sites or meetings in Germany and abroad.
1 to 10 staff
Embl Enterprise Management Technology Transfer Gmbh
EMBLEM, founded in is the wholly owned subsidiary and exclusive technology and knowledge transfer partner of the European Molecular Biology Laboratory (EMBL). We currently manage a portfolio in excess of inventions, over 450 patent applications and granted patents, and more than 400 active license contracts with major players in the pharmaceutical, biotech and instrumentation markets.
11 to 50 staff
Emiko - Effektive Mikroorganismen
Herzlich Willkommen bei EMIKO Wir stehen für eine pestizidfreie Landwirtschaft, von der alle Menschen gesund leben können. Wir vermindern die Verschmutzung des Wassers, verbessern den ökologischen Zustand der Meere und stärken das Wohlbefinden von Mensch und Tier
11 to 50 staff
Genetek Biopharma Gmbh
GENETEK Biopharma GmbH is located in the Science city of Berlin-Adlershof: the new Hotspot of Science, Technology and Media, in Berlin. At GENETEK Biopharma, we pride ourselves in being one of the few firms providing high quality multiplex PCR kits and reagents for both healthcare, research, medical genetics diagnostics, molecular diagnosis, forensics, etc. applications.
1 to 10 staff
Ist Innuscreen Gmbh
Founded in 2005, IST Innuscreen GmbH specializes in the field of nucleic acid isolation and purification, molecular diagnostics including molecular biology reagents. The company offers a broad product portfolio of kits, assays and reagents - including kits and assays for PCR and qPCR/real-time PCR. The business areas are based on several unique technology platforms for the isolation and purification of nucleic acids, extraction of high molecular weight DNA for NGS applications, and enrichment of biomolecules such as cell-free nucleic acids, viruses, phages or subcellular particles. These platforms are protected by 38 patents and patent applications. IST Innuscreen products are the lifeline for any lab involved with low and high-volume nucleic acid extraction or detection and which wants to evolve through efficiency and testing accuracy Located in Berlin, the company is certified for ISO EN13485. In 2020, AJ Innuscreen GmbH was acquired by Innovative Sensor Technology IST AG and renamed IST Innuscreen GmbH.
11 to 50 staff
Lubera Edibles Gmbh
At Lubera Edibles, what belongs together grows together. Established as a joint venture, the innovative breeding of new edibleplants at Lubera is closely linked and coordinated with the product development and in-vitro propagation at Robert Mayer. At Lubera,new plants are bred and, after an extensive testing phase, immediately integrated into the ecommerce platform at Lubera.com. After a positive customer response, exciting varieties and concepts are quickly accepted into Robert Mayer’s young plant productionand distributed by Lubera Edibles throughout Europe. This is how the basis for a market-oriented range of plants for different groups of customers is created.
11 to 50 staff
Metanomics Health
Biocrates and Metanomics Health have merged to create a new global leader in Metabolomics and early disease detection. As a total solution provider, Biocrates and Metanomics Health provide the broadest technology and product portfolio in the industry. In addition to our unique metabolomics services offer, our team is developing new clinical biomarker assays addressing unmet medical needs as well as quality control assays to improve clinical study outcomes. Our cutting-edge technology includes state-of-the-art statistics, proprietary bioinformatics tools and biomedical expert interpretation of high quality data sets. We provide unique information about mechanisms of action, new drug targets and predictive drug safety. These decision-enabling biomedical data can accelerate drug development by reducing risk, increasing efficacy, and helping to identify therapy responders. Our Biomarker Program is focused on new diagnostic metabolic biomarkers, e.g. for congestive heart failure (CHF), early diagnosis of pancreatic cancer (PDAC), patient stratification for lung cancer treatment (LCA), non-alcoholic steatohepatitis (NASH), breast cancer (BCA), and ovarian cancer (OVCA). We are looking for collaboration partners from the pharma, nutrition, and biotech industry, as well as from universities and academic centers to further develop and market our biomarker projects. Interested in metabolomics by Metanomics Health GmbH/Biocrates Life Sciences AG? Visit or for more information.
11 to 50 staff
Provirex Genome Editing Therapies Gmbh
PROVIREX GmbH is a privately-held biotech company developing first-in-class advanced therapy medicinal products (ATMPs). PROVIREX is a spin-off of the Leibniz Institute for Virology (LIV) and is based in Hamburg, Germany. PROVIREX’s technology is based on error-free genome editing for eradication of life-threatening persistent virus infection. PROVIREX employs site-specific recombinase-based genome surgery technology to precisely excise chromosomally integrated viral genomes (proviruses). The major advantage of site-specific recombinases is that they function independently of host DNA repair. Therefore, in contrast to other gene editing technologies, they act with nucleotide precision producing completely error-free recombinants. The engineered recombinase Brec1 excises HIV-1 proviruses with high specificity from the genome of infected cells. PROVIREX’s proprietary Brec1 technology is currently entering clinical testing as first-in-human phase Ib/IIa clinical trials aiming to remove HIV-1 using gene editing of the peripheral blood (hematopoietic) stem cells of people living with HIV. PROVIREX has built GMP-compliant clean rooms at the tecHHub in Hamburg, which have also been approved by GenTSV as S3** laboratories and in which Brec1 technology will be administered as gene therapy in the future. In addition, PROVIREX will also offer CAR-T cancer therapy for people living with HIV, which is unique in Germany! PROVIREX is currently preparing its application for manufacturing authorization with the drug regulatory authority. PROVIREX is also researching ways to administer Brec1 technology more easily and directly, e.g. via LNPs. In another research project, PROVIREX is further developing another recombinase, this time to treat HTLV-1, a retrovirus closely related to HIV that causes an aggressive form of blood cancer and a progressive neurological disease.
11 to 50 staff
Qinstruments
QINSTRUMENTS is a leading provider of products and services that advance sample preparation and biomedical research. The company develops perfect solutions for mixing and temperature control of molecular samples on robotic platforms such as the "BioShake" and fast and easy-to-use accessories, which are constantly being updated. QInstruments provides excellent application support, quick technical service, and customized product demonstrations. The strong intellectual portfolio of the company consists of several own and foreign-issued patents for sample preparation. The German QINSTRUMENTS GmbH was founded in 2003 by the engineers Olaf Simmat and Christian Stange. The company consists of an interdisciplinary team of engineers, software developers, biologists, and many helping hands. All provided products are designed and manufactured in-house. Furthermore, QInstruments also runs an endurance test lab to support our customers with service on the Approval and conformity side. Customers include life-science research laboratories, university medical centers, and drug discovery laboratories in pharmaceutical and biotechnology firms. Since October 2021 QInstruments has been a member of the #BICOFamily! Together with BICO, we continue on the #BIOCONVERGENCE revolution with improved workflows and greater assurance to our customers, which will bring greater assurance to researchers. more information at
11 to 50 staff
Serengen Gmbh
Serengen is an innovative company with a mission to make hit identification fast and serendipitous discovery accessible to everyone. Our services include screening of DNA encoded libraries (DELs), tailored to your individual projects. Our technology overcomes the limitations of traditional DELs by addressing 3 key issues:(1) chemistry,(2) design, and (3) approach. Chemistry Serengen has developed a new encoding strategy which removes the barriers of DNA-compatible chemistry. It also overcomes the limitations of traditional DEL chemistry, which has often resulted in non-druglike and intractable hits associated with laborious and costly hit follow-up and a high attrition rate. Our technology allows us to choose from a variety of compatible chemical reactions which yield druglike and tractable compounds. Our DEL hits can be fed directly into lead generation, bypassing the costly and time-consuming hit follow-up process. Design Traditional DEL synthesis is limited by chemistry, but with Serengen's unique DEL technology we can harness the power of chemistry and the creativity of the chemist. A multitude of chemical reactions gives us unparalleled flexibility in DEL design, allowing us to venture into new chemical spaces and address new biological targets. With our unrivalled ability to create diversity through chemical reactions, we are pushing the boundaries of biochemistry and drug discovery. Approach We only use building blocks relevant to drug discovery and eliminate redundancies, reducing costs and time spent on hit follow-up. Our dual purification removes by-products and artifacts, reducing false positives. And our concentration adjustment reduces the risk of false negatives. Our Vision Our vision is to democratise drug discovery so that anyone striving to develop breakthrough drugs can afford the best possible chemical starting point. Book a meeting https://calendly.com/serengen to find out more about Serengen.
1 to 10 staff
Vari Bioscience Gmbh
VaRi Bioscience GmbH was founded by a team of experts from leading female health companies. We focus on the development of innovative products for women. We are situated in Berlin, Germany, but our team, partners and business scope is international.
1 to 10 staff
Young European Biotech Network - Yebn
The Young European Biotech Network (YEBN) is a non-profit organization established in 2002. Our mission is to bring together biotech associations and individuals throughout Europe, fostering international collaboration, connections, and the exchange of knowledge among our members. At YEBN, we are dedicated to bridging the gap between academia and industry. We actively support the career development of biotech students and young professionals through a variety of initiatives, including workshops, networking events, and other engaging activities. Join us today to cultivate meaningful international connections and elevate your career in the dynamic world of biotechnology!
11 to 50 staff
Zellmechanik Dresden
Imprint/Impressum: As an innovative biotechnology Start-up we are providing next-generation technology in medical diagnostics by developing label-free blood analysis assays. Our products are based on “Real-Time Deformability Cytometry” (RT-CD), a method to determine the mechanical material properties of living cells at unprecedented measurement rates. Mechanical properties of cells are governed by functionally important parts of the cell and therefore allow for direct insights into cellular (dys-)function. They constitute an emerging label-free biomarker for the understanding and evaluation of drug treatment effects, immune cell activation, stem cell differentiation, cancer prognoses, the assessment of state and quality of cultured cells. A break through application made possible by RT-DC is the mechanical hemogram. In contrast to all other methods available today we can analyse the mechanical fingerprint of white blood cells - responsible for the immune response - without the employment of cell purification methods that alter mechanical properties. For more details, check out our website
1 to 10 staff
Central Biohub Gmbh
Central BioHub eases the human biospecimen acquisition process by connecting biomedical researchers to biospecimen suppliers across the globe. Established in 2017 by a group of highly motivated scientific enthusiasts, Central BioHub continues as the leading biospecimen provider for research and development. Our zealous service is highly appreciated in the world of biomedical research. We have a long track of records and expertise in catering to the research needs of renowned pharmaceutical, biotech companies, academic institutions, and research organizations worldwide. Our inventory is vast, with millions of human biological materials sourced from different countries of the world. Our samples are well-defined, clinically annotated, and properly preserved to yield an accurate research endpoint. Quality service and customer satisfaction are paramount for us. Therefore, we handle every human biosample with ultimate precision and strict adherence to all safety standards and IRB protocols. With the growing market trust in our brand, we are proud to have the largest availability of standardized human biospecimens on our website. Valuing customer time and patience, we help to accelerate your biomedical innovation with our online human biospecimen marketplace. Researchers across the globe can order biosamples from any device directly from our website. The specially designed web filters on the website provide you with the required information about the biosamples and you can place orders with the ease of a click. Moreover, all orders are processed immediately with a secure logistics system for the fastest door-to-door delivery within 4-7 days. We value and understand our potential customer presence across the world Our services operate globally & allow us to accept orders from all countries.
11 to 50 staff
Deconjet
Disinfection of Corona Viruses
11 to 50 staff
Highqu Gmbh
Since 2013, highQu assists life science research community worldwide by fuelling it with molecular biology tools of premium quality. From the first day we strive to organize all our processes in the best way to guarantee both the consistent quality of our products and the growing satisfaction of our customers. Premium quality means to us meeting and over exceeding the expectations of our customers and business partners in the best way possible. Being especially strong in providing robust and fast enzymes for PCR and qPCR enabling direct amplification of crude samples, we are also proud to offer unique solutions for other applications, such as non-toxic DNA gel stains or room-temperature stable protein and DNA electrophoresis ladders. Our dedication to the molecular biology field has enabled us to deliver outstanding reagents to the life science market. Our customers confirm that by publishing more and more scientific publications with the great results driven by highQu enzymes and kits. In our commitment to science, we combine excellence with simplicity in order to provide the solutions that scientists constantly seek. Our protocols are short, our reagents are including all possible components, and our support is fastest you can get these days. We support researchers whose professionalism makes science come alive. We do not only provide reagents; we are proud to be good partners to our distributors worldwide and to be seen as trusted consultants among our global customer community.
1 to 10 staff
Iku
IKU allows anyone in the world to create, license, and trade bio r&d as fundable data assets. All IKU hosted projects are vetted with A.I. and the wisdom of the bio-medical crowd.
1 to 10 staff
Progen
By delivering robust and reliable viral and non-viral gene therapy tools, antibodies, proteins, and kits to scientists worldwide, we empower researchers in academia, biotech, and pharmaceutical industries and commercial manufacturers to advance scientific discovery and develop breakthrough therapies. Founded in 1983, PROGEN is one of Germany's first biotech companies. We collaborate with gene therapy experts worldwide to design innovative solutions that help scientists overcome research, analytical, and manufacturing challenges. Beyond supplying products, we partner with our customers to understand their unique needs and provide specialized support throughout their research journey. PROGEN specializes in- Advanced AAV analytical research tools and standard reagents - Highly sensitive and widely published AAV ELISA kits - Premium antibodies optimized for gene therapy applications - Lipid nanoparticle (LNP) delivery kits - Specialized antibodies and proteins for life sciences research Our commitment extends beyond product manufacturing. We strive to advance life-changing therapies by providing our customers with reliable, consistent, and high-quality tools that meet the exact demands of modern gene therapy development. Visit to explore our comprehensive catalog of advanced tools! Making gene therapy better. Together. Imprint: https://bit.ly/3uEZf2h
11 to 50 staff
Vhlgenetics
VHLGenetics is a leading service provider with three business units: in The Netherlands Dr. van Haeringen Laboratorium B.V.(VHL), in Germany Certagen GmbH and in Belgium Dr. van Haeringen Polygen bvba (VHP). For more than 25 years, DNA has been the core of the organization, serving customers with routine DNA tests in non-human species. Utilizing the latest DNA technologies has enabled the VHLGenetics to grow quickly since 1993. Nowadays, our experienced laboratories offer more than 500 routine DNA tests for animals, plants and microorganisms. A few examples of routine tests in the portfolio of VHLGenetics include parentage verification, genotyping genetic traits like causal mutations, coat variation and the detection of pathogens (ParaTBC or QFever). For more information, please visit our website at
11 to 50 staff
